Researchers at the University of Oxford have been awarded £600,000 from Cancer Research UK to create the world’s first vaccine designed to prevent ovarian cancer.

Those involved with the research say that the jab in development, known as OvarianVax, will work by teaching the immune system to recognize and attack the earliest stages of ovarian cancer.